Live Breaking News & Updates on Ameluz

Stay updated with breaking news from Ameluz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Biofrontera Files sNDA for Increased Dosage of Aminolevulinic Acid Hydrochloride for Actinic Keratosis

The FDA set its target action date for October, with this sNDA being supported by two phase 1 safety studies on AK patients. ....

Neal Bhatia , Hermann Luebbert , Drug Administration , Biofrontera Inc , New Drug Application , Actinic Keratosis , Aminolevulinic Acid Hydrochloride ,

Biofrontera Inc. Begins Development of a Portable Photodynamic Therapy Lamp for Use with Ameluz-PDT

WOBURN, MA / ACCESSWIRE / June 1, 2023 / Biofrontera Inc. (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, announces ....

United States , Tirtht Patel , Hermann Luebbert , Biofrontera Inc , Biofrontera Inc View , Skin Cancer Foundation , Chief Executive Officer ,

Biofrontera Inc. Announces Last Patient Out in Phase I Study to Evaluate Safety and Tolerability in Treating Actinic Keratosis Using 3 Tubes of Ameluz

WOBURN, MA / ACCESSWIRE / April 26, 2023 / Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that that the last ....

United States , Biofrontera Bioscience Gmb , Biofrontera Inc , Biofrontera Inc View , Skin Cancer Foundation , Biofrontera Bioscience Gmbh , Erica Monaco , Chief Executive Officer ,